title: The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.
abstract: BACKGROUND
  The measles virus (MV) interacts with two known cellular receptors: CD46 and SLAM. The transmembrane receptor CD209 interacts with MV and augments dendritic cell infection.
  
  
  METHODS
  764 subjects previously immunized with measles-mumps-rubella vaccine were genotyped for 66 candidate SNPs in the CD46, SLAM and CD209 genes as part of a larger study.
  
  
  RESULTS
  A previously detected association of the CD46 SNP rs2724384 with measles-specific antibodies was successfully replicated in this study. Increased representation of the minor allele G for an intronic CD46 SNP was associated with an allele dose-related decrease (978 vs. 522 mIU/ml, p = 0.0007) in antibody levels. This polymorphism rs2724384 also demonstrated associations with IL-6 (p = 0.02), IFN-α (p = 0.007) and TNF-α (p = 0.0007) responses. Two polymorphisms (coding rs164288 and intronic rs11265452) in the SLAM gene that were associated with measles antibody levels in our previous study were associated with IFN-γ Elispot (p = 0.04) and IL-10 responses (p = 0.0008), respectively, in this study. We found associations between haplotypes, AACGGAATGGAAAG (p = 0.009) and GGCCGAGAGGAGAG (p < 0.001), in the CD46 gene and TNF-α secretion.
  
  
  CONCLUSIONS
  Understanding the functional and mechanistic consequences of these genetic polymorphisms on immune response variations could assist in directing new measles and potentially other viral vaccine design, and in better understanding measles immunogenetics.
authors.affiliation: Mayo Vaccine Research Group, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: Inna G
authors.initials: IG
authors.lastname: Ovsyannikova
authors.forename: Iana H
authors.initials: IH
authors.lastname: Haralambieva
authors.forename: Robert A
authors.initials: RA
authors.lastname: Vierkant
authors.forename: Megan M
authors.initials: MM
authors.lastname: O'Byrne
authors.forename: Robert M
authors.initials: RM
authors.lastname: Jacobson
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Poland
mesh_terms: D000293:Adolescent; D001741:Black or African American / Q000235:genetics; D015703:Antigens, CD / Q000235:genetics*; D015815:Cell Adhesion Molecules / Q000235:genetics*; D002648:Child; D015331:Cohort Studies; D003710:Demography; D058501:Enzyme-Linked Immunospot Assay; D005260:Female; D056726:Genetic Association Studies; D006239:Haplotypes / Q000235:genetics; D006801:Humans; D007109:Immunity / Q000235:genetics*; D056724:Immunity, Humoral / Q000235:genetics; D007371:Interferon-gamma / Q000276:immunology / Q000378:metabolism; D037181:Lectins, C-Type / Q000235:genetics*; D008297:Male; D008457:Measles / Q000276:immunology; D008458:Measles Vaccine / Q000276:immunology*; D051916:Membrane Cofactor Protein / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011956:Receptors, Cell Surface / Q000235:genetics*; D015203:Reproducibility of Results; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D044465:White People / Q000235:genetics; D055815:Young Adult; D000099215:DC-Specific ICAM-3 Grabbing Nonintegrin
chemical_list: D015703:Antigens, CD; D015815:Cell Adhesion Molecules; D007371:Interferon-gamma; D037181:Lectins, C-Type; D008458:Measles Vaccine; D051916:Membrane Cofactor Protein; D011956:Receptors, Cell Surface; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1; D014409:Tumor Necrosis Factor-alpha; D000099215:DC-Specific ICAM-3 Grabbing Nonintegrin; C497857:CD46 protein, human
references.citation: Am J Hum Genet. 2002 Feb;70(2):425-34
references.pmid: 11791212
references.citation: Semin Immunol. 2004 Feb;16(1):23-6
references.pmid: 14751760
references.citation: Nature. 2000 Aug 24;406(6798):893-7
references.pmid: 10972291
references.citation: Vaccine. 2001 Nov 12;20(3-4):430-8
references.pmid: 11672906
references.citation: Am J Hum Genet. 2004 Jan;74(1):106-20
references.pmid: 14681826
references.citation: Pharmacogenomics. 2009 May;10(5):837-52
references.pmid: 19450131
references.citation: Mutat Res. 2008 Jul-Aug;659(1-2):147-57
references.pmid: 18565787
references.citation: J Exp Med. 1994 Jan 1;179(1):353-8
references.pmid: 8270880
references.citation: J Virol. 2002 Aug;76(15):7460-7
references.pmid: 12097558
references.citation: J Gen Virol. 2002 Jun;83(Pt 6):1431-1436
references.pmid: 12029158
references.citation: Nature. 1995 Jul 20;376(6537):260-3
references.pmid: 7617038
references.citation: Nat Rev Immunol. 2001 Nov;1(2):135-45
references.pmid: 11905821
references.citation: J Virol. 1993 Oct;67(10):6025-32
references.pmid: 8371352
references.citation: Virology. 2000 Aug 15;274(1):5-10
references.pmid: 10936082
references.citation: Hum Genet. 2010 Feb;127(2):207-21
references.pmid: 19902255
references.citation: Clin Pharmacol Ther. 2007 Dec;82(6):653-64
references.pmid: 17971814
references.citation: Hum Genet. 2001 Jul;109(1):121-4
references.pmid: 11479744
references.citation: Genet Epidemiol. 2008 Apr;32(3):215-26
references.pmid: 18161052
references.citation: Clin Vaccine Immunol. 2008 Jul;15(7):1054-9
references.pmid: 18463223
references.citation: Vaccine. 2001 Mar 21;19(17-19):2434-9
references.pmid: 11257374
references.citation: Eur J Immunol. 2001 Sep;31(9):2741-50
references.pmid: 11536173
references.citation: PLoS Pathog. 2008 Apr 18;4(4):e1000049
references.pmid: 18421379
references.citation: Hum Genet. 2011 Oct;130(4):547-61
references.pmid: 21424379
references.citation: Virology. 2002 Aug 1;299(2):155-61
references.pmid: 12202217
references.citation: Hum Immunol. 2010 Apr;71(4):383-91
references.pmid: 20079393
references.citation: J Virol. 2001 Feb;75(4):1594-600
references.pmid: 11160657
references.citation: J Immunol. 1999 Dec 1;163(11):5860-70
references.pmid: 10570270
references.citation: J Allergy Clin Immunol. 2007 Sep;120(3):666-72
references.pmid: 17560639
references.citation: J Infect Dis. 2010 Jan 15;201(2):207-13
references.pmid: 20001730
references.citation: PLoS Genet. 2006 Oct 6;2(10):e150
references.pmid: 17029559
references.citation: J Infect Dis. 2007 Jan 1;195(1):21-9
references.pmid: 17152005
references.citation: J Virol. 2006 Apr;80(7):3477-86
references.pmid: 16537615
references.citation: Bioinformatics. 2005 Jan 15;21(2):263-5
references.pmid: 15297300
references.citation: Immunol Cell Biol. 1997 Apr;75(2):202-5
references.pmid: 9107577
references.citation: Cytokine. 2006 Nov;36(3-4):173-9
references.pmid: 17234427
references.citation: Genes Immun. 2007 Jan;8(1):13-20
references.pmid: 17082759
references.citation: EMBO J. 1999 Jun 1;18(11):2911-22
references.pmid: 10357804
references.citation: Immunogenetics. 2010 Apr;62(4):197-210
references.pmid: 20217072
references.citation: Viral Immunol. 2002;15(3):451-71
references.pmid: 12479395
references.citation: Cell. 1993 Oct 22;75(2):295-305
references.pmid: 8402913
references.citation: J Virol. 2000 May;74(9):3967-74
references.pmid: 10756008
references.citation: Lancet. 2005 Oct 8;366(9493):1315-23
references.pmid: 16214603
references.citation: Virology. 2001 Jan 5;279(1):9-21
references.pmid: 11145884
references.citation: Nature. 2007 Jun 7;447(7145):655-60
references.pmid: 17554299
references.citation: J Med Virol. 2003 May;70(1):131-6
references.pmid: 12629654
references.citation: Nat Rev Microbiol. 2006 Dec;4(12):900-8
references.pmid: 17088933
references.citation: J Infect Dis. 2006 Mar 1;193(5):655-63
references.pmid: 16453260
references.citation: J Gen Virol. 2003 May;84(Pt 5):1189-1197
references.pmid: 12692284
references.citation: J Immunol. 1991 May 15;146(10):3444-51
references.pmid: 1827484
references.citation: BMC Immunol. 2010 Oct 05;11:48
references.pmid: 20923569
references.citation: J Virol. 2003 Apr;77(7):4396-400
references.pmid: 12634396
references.citation: J Exp Med. 1997 Mar 17;185(6):993-1004
references.pmid: 9091591